Accessibility: Skip TopNav
A Race Against Blindness Awards Additional $1.1 Million Grant to Ensure Advancement of AXV-101 into Clinical Trial for Bardet-Biedl Syndrome 1 (BBS1)
Newly added funding closes critical gap and enables planned trial initiation in early 2026
Format
PNG
Source
A Race Against Blindness
Downloads
Original
Large
Medium
Small